home / stock / ptpi / ptpi quote
Last: | $0.6701 |
---|---|
Change Percent: | 0.27% |
Open: | $0.696 |
Close: | $0.6701 |
High: | $0.7 |
Low: | $0.67 |
Volume: | 152,623 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.6701 | $0.696 | $0.6701 | $0.7 | $0.67 | 152,623 | 04-19-2024 |
$0.6979 | $0.7 | $0.6979 | $0.729 | $0.652 | 231,705 | 04-18-2024 |
$0.69 | $0.68 | $0.69 | $0.7329 | $0.640101 | 459,109 | 04-17-2024 |
$0.705 | $0.8602 | $0.705 | $0.9 | $0.6602 | 1,985,006 | 04-16-2024 |
$0.7831 | $0.8181 | $0.7831 | $0.8181 | $0.7385 | 544,674 | 04-15-2024 |
$0.8339 | $0.9 | $0.8339 | $0.9146 | $0.8261 | 348,465 | 04-12-2024 |
$0.91 | $0.875 | $0.91 | $0.94 | $0.8416 | 357,841 | 04-11-2024 |
$0.8856 | $0.9059 | $0.8856 | $0.9059 | $0.8126 | 378,129 | 04-10-2024 |
$0.911 | $0.9297 | $0.911 | $0.9375 | $0.89 | 209,165 | 04-09-2024 |
$0.9313 | $0.92 | $0.9313 | $0.95245 | $0.8804 | 395,400 | 04-08-2024 |
$0.9251 | $0.9488 | $0.9251 | $0.954 | $0.92 | 252,831 | 04-05-2024 |
$0.954 | $0.959 | $0.954 | $0.999 | $0.9108 | 433,934 | 04-04-2024 |
$0.93 | $1.01 | $0.93 | $1.03 | $0.9 | 1,323,533 | 04-03-2024 |
$1.07 | $1.21 | $1.07 | $1.22 | $1.01 | 2,033,269 | 04-02-2024 |
$1.4 | $1.43 | $1.4 | $1.48 | $1.39 | 378,209 | 04-01-2024 |
$1.48 | $1.47 | $1.48 | $1.5195 | $1.4201 | 378,806 | 03-29-2024 |
$1.48 | $1.47 | $1.48 | $1.5195 | $1.4201 | 378,806 | 03-28-2024 |
$1.45 | $1.48 | $1.45 | $1.52 | $1.39 | 763,806 | 03-27-2024 |
$1.55 | $1.58 | $1.55 | $1.58 | $1.48 | 750,161 | 03-26-2024 |
$1.57 | $1.49 | $1.57 | $1.59 | $1.46 | 601,584 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Petros Pharmaceuticals Inc. Company Name:
PTPI Stock Symbol:
NASDAQ Market:
(Please see important safety information below) NEW YORK, NY / ACCESSWIRE / April 16, 2024 / Petros Pharmaceuticals, Inc. ("Petros," or the "Company") (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- counter (OTC) drug development programs, announ...
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. Stryve Foods post...
Nitrate patients subgroup demonstrated 100% correct self-selection when utilizing the web app technology with the drug facts label compared to 40% when using drug facts label alone (among 86% vs. 56% of all users) underscoring the significant potential benefits of technology assistance in an OTC ...